Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Account Payables: 2019-2024

Historic Change in Account Payables for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to $723,000.

  • Maravai Lifesciences Holdings' Change in Account Payables fell 20.08% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $422,000, marking a year-over-year increase of 229.69%. This contributed to the annual value of $723,000 for FY2024, which is 86.32% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Change in Account Payables stood at $723,000 for FY2024, which was down 86.32% from $5.3 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Change in Account Payables registered a high of $5.3 million during FY2023, and its lowest value of -$1.6 million during FY2022.
  • Its 3-year average for Change in Account Payables is $1.5 million, with a median of $723,000 in 2024.
  • In the last 5 years, Maravai Lifesciences Holdings' Change in Account Payables tumbled by 333.43% in 2022 and then spiked by 434.85% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Change in Account Payables (Yearly) stood at $1.2 million in 2020, then slumped by 42.52% to $676,000 in 2021, then slumped by 333.43% to -$1.6 million in 2022, then spiked by 434.85% to $5.3 million in 2023, then crashed by 86.32% to $723,000 in 2024.